Annie M. Frimm

Single-Dose Safety and Pharmacokinetics of ST-246, a Novel Orthopoxvirus Egress Inhibitor

Kevin F. Jones, R. Jordan, D. Hruby, 2008, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetics of the Anti-Orthopoxvirus Compound ST-246 following a Single Daily Oral Dose for 14 Days in Human Volunteers

Kevin F. Jones, R. Jordan, J. Leeds, 2012, Antimicrobial Agents and Chemotherapy.

Pharmacokinetic Comparison of a Single Oral Dose of Polymorph Form I versus Form V Capsules of the Antiorthopoxvirus Compound ST-246 in Human Volunteers

Kevin F. Jones, R. Jordan, T. Marbury, 2012, Antimicrobial Agents and Chemotherapy.

ST-246 Antiviral Efficacy in a Nonhuman Primate Monkeypox Model: Determination of the Minimal Effective Dose and Human Dose Justification

Chelsea M. Byrd, J. Shamblin, R. Jordan, 2009, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects

Kevin F. Jones, R. Jordan, T. Marbury, 2010, Antimicrobial Agents and Chemotherapy.

Safety and Pharmacokinetics of the Antiorthopoxvirus Compound ST-246 following Repeat Oral Dosing in Healthy Adult Subjects (cid:1)

Kevin F. Jones, R. Jordan, T. Marbury, 2010 .